Skip to content
Licensed Unlicensed Requires Authentication Published by De Gruyter September 23, 2017

Interlaboratory variability of urinary iodine measurements

  • Till Ittermann EMAIL logo , Simone Johner , Harald Below , Matthias Leiterer , Michael Thamm , Thomas Remer and Henry Völzke

Abstract

Background:

The iodine status of populations is usually assessed by median urinary iodine concentrations (UIC) in population-based studies, but it is unclear to which extent UIC are comparable across different laboratories. The aim of our study was to investigate the variability of UIC measurements across three well-established German laboratories with long-term clinical-chemical expertise in iodine measurements and to compare these results to the gold standard inductively coupled plasma mass spectrometry (ICP-MS).

Methods:

UIC levels were measured from 303 urine samples derived from the “Dortmund Nutritional and Anthropometric Longitudinally Designed Study” and from volunteers of the University Medicine Greifswald at four different German laboratories. Three of these laboratories used Sandell-Kolthoff reaction with different digestion methods for UIC measurement (Lab1–Lab3), whereas one laboratory used ICP-MS as gold standard.

Results:

Median UIC levels were significantly different across the four laboratories (ICP-MS: 77 μg/L; Lab1: 69 μg/L; Lab2: 73 μg/L; Lab3: 111 μg/L). Linear regressions associating UIC levels of Lab1–Lab3 with UIC levels of ICP-MS showed intercepts significantly different from 0 and slopes significantly different from 1. Intraclass correlations (ICC) in comparison to ICP-MS were 0.91 for Lab1, 0.98 for Lab2, and 0.69 for Lab3. Using the digestion method of Lab2 in Lab3 improved the comparison of UIC levels of Lab3 with those from the ICP-MS (ICC=0.89).

Conclusions:

We have demonstrated larger interlaboratory variations across high-quality laboratories with long-lasting experience in iodine measurements indicating a relevant non-comparability of UIC measurements in iodine monitoring studies. Therefore, standardization of UIC measurements has to be expedited.


Corresponding author: Till Ittermann, Dr. rer. med., Institute for Community Medicine, University Medicine Greifswald, Walther Rathenau Str. 48, 17475 Greifswald, Germany, Phone: +49-3834-867552, Fax: +49-3834-866684
aMichael Thamm, Thomas Remer and Henry Völzke contributed equally to this work as senior authors.
  1. Author contributions: All the authors have accepted responsibility for the entire content of this submitted manuscript and approved submission.

  2. Research funding: This work was supported by EUthyroid. The project has received funding from the European Union’s Horizon 2020 Framework Programme, research and innovation program under grant agreement number 634453.

  3. Employment or leadership: None declared.

  4. Honorarium: None declared.

  5. Competing interests: The funding organization(s) played no role in the study design; in the collection, analysis, and interpretation of data; in the writing of the report; or in the decision to submit the report for publication.

References

1. World Health Organization. Assessment of iodine deficiency disorders and monitoring their elimination. A guide for programme managers, 3rd ed. Geneva, Switzerland: WHO Press, 2007.Search in Google Scholar

2. Zimmermann MB, Andersson M. Update on iodine status worldwide. Curr Opin Endocrinol Diabetes Obes 2012;19:382–7.10.1097/MED.0b013e328357271aSearch in Google Scholar PubMed

3. Shelor CP, Dasgupta PK. Review of analytical methods for the quantification of iodine in complex matrices. Anal Chim Acta 2011;702:16–36.10.1016/j.aca.2011.05.039Search in Google Scholar PubMed

4. Caldwell KL, Maxwell CB, Makhmudov A, Pino S, Braverman LE, Jones RL, et al. Use of inductively coupled plasma mass spectrometry to measure urinary iodine in NHANES 2000: comparison with previous method. Clin Chem 2003;49:1019–21.10.1373/49.6.1019Search in Google Scholar PubMed

5. EQUIP Program. Available at: http://www.cdc.gov/labstandards/equip.html. Accessed: July 2017.Search in Google Scholar

6. Buyken AE, Alexy U, Kersting M, Remer T. The DONALD cohort. An updated overview on 25 years of research based on the Dortmund Nutritional and Anthropometric Longitudinally Designed study. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 2012;55:875–84.10.1007/s00103-012-1503-6Search in Google Scholar PubMed

7. Volzke H, Alte D, Schmidt CO, Radke D, Lorbeer R, Friedrich N, et al. Cohort profile: the study of health in Pomerania. Int J Epidemiol 2011;40:294–307.10.1093/ije/dyp394Search in Google Scholar PubMed

8. Remer T, Montenegro-Bethancourt G, Shi L. Long-term urine biobanking: storage stability of clinical chemical parameters under moderate freezing conditions without use of preservatives. Clin Biochem 2014;47:307–11.10.1016/j.clinbiochem.2014.09.009Search in Google Scholar PubMed

9. Leiterer M, Truckenbrodt D, Franke K. Determination of iodine species in milk using ion chromatographic separation and ICP-MS detection. Eur Food Res Technol 2001;213:150–3.10.1007/s002170100333Search in Google Scholar

10. Benotti J, Benotti N, Pino S, Gardyna H. Determination of total iodine in urine, stool, diets, and tissue. Clin Chem 1965;11:932–6.10.1093/clinchem/11.10.932Search in Google Scholar

11. Pino S, Fang SL, Braverman LE. Ammonium persulfate: a safe alternative oxidizing reagent for measuring urinary iodine. Clin Chem 1996;42:239–43.10.1093/clinchem/42.2.239Search in Google Scholar

12. Zimmermann MB, Aeberli I, Andersson M, Assey V, Yorg JA, Jooste P, et al. Thyroglobulin is a sensitive measure of both deficient and excess iodine intakes in children and indicates no adverse effects on thyroid function in the UIC range of 100–299 mug/L: a UNICEF/ICCIDD study group report. J Clin Endocrinol Metab 2013;98:1271–80.10.1210/jc.2012-3952Search in Google Scholar PubMed

13. Spencer CA, Takeuchi M, Kazarosyan M, Wang CC, Guttler RB, Singer PA, et al. Serum thyroglobulin autoantibodies: prevalence, influence on serum thyroglobulin measurement, and prognostic significance in patients with differentiated thyroid carcinoma. J Clin Endocrinol Metab 1998;83:1121–7.10.1210/jc.83.4.1121Search in Google Scholar

14. Shan Z, Chen L, Lian X, Liu C, Shi B, Shi L, et al. Iodine status and prevalence of thyroid disorders after introduction of mandatory universal salt iodization for 16 years in china: a cross-sectional study in 10 cities. Thyroid 2016;26:1125–30.10.1089/thy.2015.0613Search in Google Scholar PubMed

15. Koukkou E, Ilias I, Mamalis I, Adonakis GG, Markou KB. Serum thyroglobulin concentration is a weak marker of iodine status in a pregnant population with iodine deficiency. Eur Thyroid J 2016;5:120–4.10.1159/000446070Search in Google Scholar PubMed PubMed Central

Received: 2017-7-3
Accepted: 2017-7-31
Published Online: 2017-9-23
Published in Print: 2018-2-23

©2018 Walter de Gruyter GmbH, Berlin/Boston

Downloaded on 25.4.2024 from https://www.degruyter.com/document/doi/10.1515/cclm-2017-0580/html
Scroll to top button